|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,126,444 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,065,294 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
8,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-04-30 |
4 |
A |
$10.93 |
$16,648 |
D/D |
1,523 |
13,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-21 |
4 |
AS |
$56.19 |
$86,817 |
I/I |
(1,545) |
47,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-04-29 |
4 |
A |
$11.64 |
$21,249 |
D/D |
1,826 |
91,893 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-04-30 |
4 |
A |
$11.64 |
$21,260 |
D/D |
1,827 |
50,567 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
10,844 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-21 |
4 |
AS |
$18.54 |
$37,123 |
D/D |
(2,000) |
15,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-07-05 |
4 |
AS |
$18.21 |
$36,582 |
D/D |
(2,000) |
8,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-08-03 |
4 |
AS |
$18.00 |
$36,053 |
D/D |
(2,000) |
6,695 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2007-09-10 |
4 |
B |
$8.61 |
$17,357 |
D/D |
2,000 |
15,821 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-03 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
27,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-03 |
4 |
S |
$38.10 |
$76,239 |
D/D |
(2,000) |
11,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-08-07 |
4 |
S |
$15.95 |
$31,902 |
D/D |
(2,000) |
57,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-08-10 |
4 |
S |
$15.69 |
$31,889 |
D/D |
(2,000) |
55,440 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-11-20 |
4 |
S |
$8.40 |
$16,865 |
D/D |
(2,000) |
13,621 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2010-05-24 |
4 |
S |
$8.06 |
$16,131 |
D/D |
(2,000) |
10,121 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-02 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
97,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-08 |
4 |
S |
$25.78 |
$51,569 |
D/D |
(2,000) |
93,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-08 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
95,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-12-06 |
4/A |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
95,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-12-06 |
4/A |
S |
$27.17 |
$54,348 |
D/D |
(2,000) |
93,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-06-06 |
4 |
S |
$27.39 |
$54,772 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-19 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-19 |
4 |
S |
$26.75 |
$53,496 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-30 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
129,093 |
0 |
- |
|
850 Records found
|
|
Page 9 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|